Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-2763.64%
operating margin TTM
-2999.38%
revenue TTM
45.67 Million
revenue per share TTM
0.21$
valuation ratios | |
|---|---|
| pe ratio | -12.07 |
| peg ratio | -0.55 |
| price to book ratio | 4.32 |
| price to sales ratio | 401.19 |
| enterprise value multiple | -14.79 |
| price fair value | 4.32 |
profitability ratios | |
|---|---|
| gross profit margin | -566.59% |
| operating profit margin | -2999.38% |
| pretax profit margin | -2763.64% |
| net profit margin | -2763.64% |
| return on assets | -29.57% |
| return on equity | -42.27% |
| return on capital employed | -33.87% |
liquidity ratios | |
|---|---|
| current ratio | 18.27 |
| quick ratio | 18.27 |
| cash ratio | 2.39 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 60.62 |
| cash conversion cycle | -60.62 |
| receivables turnover | 0.00 |
| payables turnover | 6.02 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.03 |
| debt equity ratio | 0.03 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.03 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -6.92 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.05 |
| cash per share | 4.49 |
| operating cash flow per share | -1.05 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -6.92 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time Relay Therapeutics, Inc. (NASDAQ:RLAY) reported earnings?
Relay Therapeutics, Inc. (RLAY) published its most recent earnings results on 06-08-2026.
What is Relay Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Relay Therapeutics, Inc. (NASDAQ:RLAY)'s trailing twelve months ROE is -42.27%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Relay Therapeutics, Inc. (RLAY) currently has a ROA of -29.57%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did RLAY's net profit margin stand at?
RLAY reported a profit margin of -2763.64% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is RLAY's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 18.27 in the most recent quarter. The quick ratio stood at 18.27, with a Debt/Eq ratio of 0.03.